Live recombinant vaccines using genetically engineered vaccinia virus

Antiviral Res. 1985:Suppl 1:301-7. doi: 10.1016/s0166-3542(85)80042-5.
No abstract available

MeSH terms

  • Animals
  • Antibodies, Viral / biosynthesis*
  • Antibodies, Viral / genetics
  • Antigens, Viral / genetics*
  • Antigens, Viral / immunology
  • DNA, Recombinant*
  • Genes, Viral
  • Genetic Engineering
  • Hepatitis B Surface Antigens / genetics
  • Hepatitis B Surface Antigens / immunology
  • Immunity, Cellular
  • Immunization, Secondary
  • Rabbits
  • Serotyping
  • Time Factors
  • Vaccination
  • Vaccinia virus / genetics
  • Vaccinia virus / immunology*
  • Viral Envelope Proteins*
  • Viral Proteins / genetics
  • Viral Proteins / immunology
  • Viral Vaccines* / immunology

Substances

  • Antibodies, Viral
  • Antigens, Viral
  • DNA, Recombinant
  • Hepatitis B Surface Antigens
  • Viral Envelope Proteins
  • Viral Proteins
  • Viral Vaccines
  • glycoprotein D, Human herpesvirus 1